CDLX

Cardlytics, Inc. (CDLX) | Rumor.io

Cardlytics

CDLX

Attention (50-day avg)0%

Attention rank (50-day avg)#3,230

Bullish sentiment (50-day avg)65%

Price to earnings ratio-0.16

Market capitalization18.5M

Earnings per share-20.4

Dividend yield (TTM)—

Revenue (annual)233.3M

Net income (annual)-103.5M

Social

What share of all stock conversation is about CDLX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 8

Cardlytics, Inc. (CDLX) has been trading at low prices, with some posts suggesting it needs to rise from its current levels.
The company's CFO, David Thomas Evans, has purchased 200,000 CDLX shares, indicating a positive sentiment from management.
Clifford Sosin's large purchase of CDLX shares at $0.80 has been criticized by some, who question his investment decision.

Generated by AI

Sentiment

Of the messages about CDLX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +37.5	86% -0.77
Bearish	—	—	0% -37.5	14% +0.77

Bullish· Oct 6

$CDLX is setting up for a potential breakout, with a strong first leg of a new trend and a valid consolidation forming a VCP against the 8/20 EMA layer.
Cardlytics, Inc. has a low price-to-sales ratio, making it undervalued with a target price of $4, and participation in pricing could help the stock rebound.
$CDLX is poised for a significant price increase, potentially reaching $10+ in the long term, with a 5X opportunity due to its strategic investments and undervalued status.

Bearish· Sep 19

The asset's price is expected to drop significantly, with some predicting a 100x decrease.
A large number of short positions are trapped at a low price, which could lead to a break and further price decline.
The company may engage in a manipulation tactic, such as a triple witch squeeze, to drive the price down.

Generated by AI

Topics

Of the messages about CDLX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	41.58%
Earnings	—	—	—	17.87%
Analysts	—	—	—	0.86%
Controversies	—	—	—	0.43%
Macro	—	—	—	11%
Technical Analysis	—	—	—	28.26%

Earnings· Aug 14

Cardlytics, Inc. (CDLX) reported earnings that beat estimates by $0.32 in EPS and slightly beat on revenues.
The company's Q2 earnings call is scheduled for 5pm Eastern, and will be streamed live or available on replay.
CDLX's earnings results included a loss of $0.62, which was less than the consensus estimate of a loss of $0.48.

Analysts· May 12

Cardlytics ($CDLX) price target has been raised to $52.00 by JPMorgan Chase & Co. with a neutral recommendation.
Wells Fargo and SunTrust Banks have also raised the price target to $55.00 with an overweight and buy recommendation, respectively.
Craig Hallum has lowered the price target to $50.00.

Announcements· Sep 18

Cardlytics, Inc. (CDLX) has repaid its remaining $46.1 million convertible senior notes due on September 15, 2025.
The company expects to be adjusted EBITDA positive this year and next year, following the repayment of its debt.
Cardlytics' user base has grown to 224.5 million, with a 19% year-over-year increase, and the company has turned its adjusted EBITDA positive in Q2.

Technical Analysis· Sep 18

$CDLX needs to clear and hold $3.06 to confirm a potential buy signal.
The stock has broken out of a bull pennant and is forming a long-term triangle breakout, with potential for a massive reversal if it confirms above $3.
The 5-minute chart shows a bullish pennant forming, indicating a potential target around $3.90 if validated.

Generated by AI

Community

Of the messages about CDLX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	66.67%	26.06%
Newcomers	—	—	33.33%	73.94%

Regulars· Aug 2

The company has seen significant growth, with a +310% YTD increase due to a strong Q2 beat, with the regulars feeling that there's still room for improvement in the bottom line and share price.
Needham has raised the price target for CDLX from $10 to $19, citing "solid results" and a "favorable risk-reward" for small-cap growth investors.
The company has seen significant valuation growth, with a market cap now exceeding $400M, and regulars are optimistic about potential future scaling and revenue growth, especially with the new user experience now being used by 100% of Chase users.

Newcomers· Mar 5

The company has reported strong Q4 and FY2025 earnings, with a revenue beat and improved cash flow, leading to an 8.5% stock increase.
Many users are optimistic about the company's prospects, citing a significant improvement in Adjusted EBITDA and a cleaned balance sheet as key inflection points.
There is a sense of excitement and anticipation among users, with some even mentioning the possibility of the company making history with its numbers and others expressing hope that the market will recognize the company's turnaround.

Generated by AI

News

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Detailed price information for Cardlytics Inc (CDLX-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Cardlytics, Inc. Q2 2026 Earnings Call Summary

1mo agoYahoo Finance

Earnings call transcript: Cardlytics Q2 2026 results show recovery signs

1mo agoInvesting.com

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

ATLANTA, August 05, 2026--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026.

1mo agoYahoo Finance

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, August 03, 2026--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the "2022 Inducement Plan").

1mo agoYahoo Finance

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, July 31, 2026--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the "2022 Inducement Plan").

2mo agoYahoo Finance

Also Discussed

Investors talking about CDLX also mention

#	Name	Attention
1	EverQuote Inc. Class A Common StockEVER	0%0
2	Carvana Co. Class A Common StockCVNA	0.01%-0.02
3	People IncorporatedIAC	0%new
4	AYX - Alteryx, Inc.	——
5	Rani Therapeutics Holdings, Inc. Class A Common StockRANI	0%0
6	Fathom Holdings Inc.FTHM	0%0
7	Tigo Energy, Inc. Common StockTYGO	0%0
8	Par Technology Corp.PAR	0%0
9	The Joint Corp.JYNT	0%0
10	TIC Solutions, Inc.TIC	0%0

Cardlytics, Inc.

Communication Services
Advertising Agencies

Cardlytics, Inc. is a commerce media company that helps advertisers reach consumers through purchase-based marketing across digital banking channels. The company operates a native bank advertising platform and a customer data platform that use first-party transaction and point-of-sale data to deliver targeted offers, loyalty marketing, and campaign measurement. Its solutions are designed to connect brands with audiences inside online banking, mobile apps, email, and real-time notifications, while also helping publishers enhance user engagement and customer rewards. Cardlytics serves advertisers and financial institution partners in the United States and the United Kingdom, with a focus on card-linked offers and measurable commerce outcomes. Headquartered in Atlanta, Georgia, Cardlytics plays a role in the growing market for data-driven advertising by linking consumer spending behavior with personalized marketing experiences.

Website

Location

675 Ponce de Leon Avenue NE

Atlanta, GA, 30308

United States

Social

What share of all stock conversation is about CDLX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 8

Cardlytics, Inc. (CDLX) has been trading at low prices, with some posts suggesting it needs to rise from its current levels.
The company's CFO, David Thomas Evans, has purchased 200,000 CDLX shares, indicating a positive sentiment from management.
Clifford Sosin's large purchase of CDLX shares at $0.80 has been criticized by some, who question his investment decision.

Generated by AI

Sentiment

Of the messages about CDLX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +37.5	86% -0.77
Bearish	—	—	0% -37.5	14% +0.77

Bullish· Oct 6

$CDLX is setting up for a potential breakout, with a strong first leg of a new trend and a valid consolidation forming a VCP against the 8/20 EMA layer.
Cardlytics, Inc. has a low price-to-sales ratio, making it undervalued with a target price of $4, and participation in pricing could help the stock rebound.
$CDLX is poised for a significant price increase, potentially reaching $10+ in the long term, with a 5X opportunity due to its strategic investments and undervalued status.

Bearish· Sep 19

The asset's price is expected to drop significantly, with some predicting a 100x decrease.
A large number of short positions are trapped at a low price, which could lead to a break and further price decline.
The company may engage in a manipulation tactic, such as a triple witch squeeze, to drive the price down.

Generated by AI

Topics

Of the messages about CDLX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	41.58%
Earnings	—	—	—	17.87%
Analysts	—	—	—	0.86%
Controversies	—	—	—	0.43%
Macro	—	—	—	11%
Technical Analysis	—	—	—	28.26%

Earnings· Aug 14

Cardlytics, Inc. (CDLX) reported earnings that beat estimates by $0.32 in EPS and slightly beat on revenues.
The company's Q2 earnings call is scheduled for 5pm Eastern, and will be streamed live or available on replay.
CDLX's earnings results included a loss of $0.62, which was less than the consensus estimate of a loss of $0.48.

Analysts· May 12

Cardlytics ($CDLX) price target has been raised to $52.00 by JPMorgan Chase & Co. with a neutral recommendation.
Wells Fargo and SunTrust Banks have also raised the price target to $55.00 with an overweight and buy recommendation, respectively.
Craig Hallum has lowered the price target to $50.00.

Announcements· Sep 18

Cardlytics, Inc. (CDLX) has repaid its remaining $46.1 million convertible senior notes due on September 15, 2025.
The company expects to be adjusted EBITDA positive this year and next year, following the repayment of its debt.
Cardlytics' user base has grown to 224.5 million, with a 19% year-over-year increase, and the company has turned its adjusted EBITDA positive in Q2.

Technical Analysis· Sep 18

$CDLX needs to clear and hold $3.06 to confirm a potential buy signal.
The stock has broken out of a bull pennant and is forming a long-term triangle breakout, with potential for a massive reversal if it confirms above $3.
The 5-minute chart shows a bullish pennant forming, indicating a potential target around $3.90 if validated.

Generated by AI

Community

Of the messages about CDLX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	66.67%	26.06%
Newcomers	—	—	33.33%	73.94%

Regulars· Aug 2

The company has seen significant growth, with a +310% YTD increase due to a strong Q2 beat, with the regulars feeling that there's still room for improvement in the bottom line and share price.
Needham has raised the price target for CDLX from $10 to $19, citing "solid results" and a "favorable risk-reward" for small-cap growth investors.
The company has seen significant valuation growth, with a market cap now exceeding $400M, and regulars are optimistic about potential future scaling and revenue growth, especially with the new user experience now being used by 100% of Chase users.

Newcomers· Mar 5

The company has reported strong Q4 and FY2025 earnings, with a revenue beat and improved cash flow, leading to an 8.5% stock increase.
Many users are optimistic about the company's prospects, citing a significant improvement in Adjusted EBITDA and a cleaned balance sheet as key inflection points.
There is a sense of excitement and anticipation among users, with some even mentioning the possibility of the company making history with its numbers and others expressing hope that the market will recognize the company's turnaround.

Generated by AI

Cardlytics

Social

Jun 8

Bullish· Oct 6

Bearish· Sep 19

Earnings· Aug 14

Analysts· May 12

Announcements· Sep 18

Technical Analysis· Sep 18

Regulars· Aug 2

Newcomers· Mar 5

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics, Inc. Q2 2026 Earnings Call Summary

Earnings call transcript: Cardlytics Q2 2026 results show recovery signs

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Also Discussed

Cardlytics, Inc.

Company Information

Location

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics, Inc. Q2 2026 Earnings Call Summary

Earnings call transcript: Cardlytics Q2 2026 results show recovery signs

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Also Discussed

Social

Jun 8

Bullish· Oct 6

Bearish· Sep 19

Earnings· Aug 14

Analysts· May 12

Announcements· Sep 18

Technical Analysis· Sep 18

Regulars· Aug 2

Newcomers· Mar 5